Try our Advanced Search for more refined results

November 18, 2010

Promote Innovation LLC v. Bristol-Myers Squibb Company

Track this case

Case Number:

2:10-cv-00497

Court:

Texas Eastern

Nature of Suit:

Patent

Judge:

T. John Ward

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. November 19, 2010

    Bristol-Myers Hit With False Marking Suit Over 3 Drugs

    Frequent qui tam plaintiff Promote Innovation LLC has accused Bristol-Myers Squibb Co. of marking its antibiotic Cefzil, its anti-anxiety medication Buspar and its cholesterol drug Pravachol with expired or inapplicable patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!